Latest Share Chat

REMOVE ADS

Cambridge Cog Share News (COG)

Cambridge Cog Information

Share Price Information for Cambridge Cog (COG)

Share Price is delayed by 15 minutes

Get Live Data

36.00 0.00 (0.00%)

Bid:

0.00

Ask:

0.00

Spread: 2.00 (5.714%)

Market Cap: £16.76m

Last checked at -

Intraday Cambridge Cog Share Chart

REMOVE ADS

Cambridge Cog News

Lombard Odier Asset Management Holds 5.8% Cambridge Cognition Stake (ALLISS)

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that Lombard Odier Asset Management Europe Ltd holds a 5.75% stake in the cogn...

Cambridge Cognition slips as low order intake sends loss deeper

(Sharecast News) - Cambridge Cognition's shares slipped on Thursday after it reported that low order intake from 2017 had caused its annual losses to ...

Cambridge Cognition soars on Indian software partnership

(Sharecast News) - Cambridge Cognition leapt on Thursday after entering a partnership with a major pharmaceutical company to deliver online neurologic...

Cambridge Cognition shares tumble as revenues fall short of expectations

(Sharecast News) - Neuroscience technology developer Cambridge Cognition has seen revenues fall short of expectations and losses widen as a result of ...

Cambridge Cognition Holdings Loss Widens As Revenue Drops

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that its loss for the first half of the financial year widened as it recorded ...

Cambridge Cognition To Provide NeuroVocalix For Virtual Clinical Tests

LONDON (Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it signed its first commercial contract with an undisclosed pharmaceutical...

Cambridge Cognition announces first NeuroVocalix commercial partnership

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced its first commercial partnership for its recently launched '...

Cambridge Cognition's NeuroVocalix Set For Clinical Trial Use

LONDON (Alliance News) - Neuroscience technology firm Cambridge Cognition Holdings PLC on Thursday said its NeuroVocalix platform is ready for clinica...